Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Clinical Pharmacology and Therapeutics|September 6, 2006
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart diseaseGiulia Renda, Stefania Tacconelli, Marta L Capone, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 20, 2024
Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's diseaseChantal M Ferguson, Samuel Hildebrand, Bruno M D C Godinho, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 22, 2019
Multicenter Alzheimer's and Parkinson's disease immune biomarker verification studyFrederic Brosseron, Carl-Christian Kolbe, Francesco Santarelli, et al.
Nature|January 3, 2018
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's diseaseCarmen Venegas, Sathish Kumar, Bernardo S Franklin, et al.
Nature|November 22, 2019
NLRP3 inflammasome activation drives tau pathologyChristina Ising, Carmen Venegas, Shuangshuang Zhang, et al.
Immunity|February 4, 2025
NLRP3-mediated glutaminolysis controls microglial phagocytosis to promote Alzheimer's disease progressionRóisín M McManus, Max P Komes, Angelika Griep, et al.
Alzheimer'S Research & Therapy|January 11, 2023
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE studyFrederic Brosseron, Anne Maass, Luca Kleineidam, et al.
Neuron|January 7, 2022
Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's diseaseFrederic Brosseron, Anne Maass, Luca Kleineidam, et al.
Pageof 3